Reply: Contrasting effect of iron supplementation in protoporphyria
Hepatology
.
2024 Mar 1;79(3):E89-E90.
doi: 10.1097/HEP.0000000000000640.
Epub 2023 Oct 20.
Authors
Cynthia Levy
1
,
Amy K Dickey
2
3
,
Karl E Anderson
4
,
Sioban B Keel
5
,
Manisha Balwani
6
Affiliations
1
Division of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, Florida, USA.
2
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
3
Harvard Medical School, Boston, Massachusetts, USA.
4
Department of Internal Medicine, Division of Gastroenterology & Hepatology, University of Texas Medical Branch/UTMB Health, Galveston, Texas, USA.
5
Division of Hematology, University of Washington School of Medicine, Seattle, Washington, USA.
6
Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
PMID:
37862462
DOI:
10.1097/HEP.0000000000000640
No abstract available
MeSH terms
Dietary Supplements
Humans
Iron* / therapeutic use
Protoporphyria, Erythropoietic* / drug therapy
Substances
Iron